In the past week, PROK stock has gone up by 22.03%, with a monthly decline of -23.24% and a quarterly plunge of -54.86%. The volatility ratio for the week is 26.72%, and the volatility levels for the last 30 days are 16.07% for ProKidney Corp The simple moving average for the past 20 days is -11.96% for PROK’s stock, with a -59.03% simple moving average for the past 200 days.
Is It Worth Investing in ProKidney Corp (NASDAQ: PROK) Right Now?
PROK has 36-month beta value of 1.69. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for PROK is 93.47M, and currently, short sellers hold a 12.76% ratio of that float. The average trading volume of PROK on April 14, 2025 was 562.61K shares.
PROK) stock’s latest price update
The stock of ProKidney Corp (NASDAQ: PROK) has increased by 19.20 when compared to last closing price of 0.61.Despite this, the company has seen a gain of 22.03% in its stock price over the last five trading days. zacks.com reported 2025-03-21 that PROKIDNEY CP (PROK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Analysts’ Opinion of PROK
Guggenheim, on the other hand, stated in their research note that they expect to see PROK reach a price target of $6. The rating they have provided for PROK stocks is “Buy” according to the report published on September 10th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to PROK, setting the target price at $3 in the report published on March 07th of the previous year.
PROK Trading at -36.12% from the 50-Day Moving Average
After a stumble in the market that brought PROK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.53% of loss for the given period.
Volatility was left at 16.07%, however, over the last 30 days, the volatility rate increased by 26.72%, as shares sank -25.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.21% lower at present.
During the last 5 trading sessions, PROK rose by +22.03%, which changed the moving average for the period of 200-days by -67.21% in comparison to the 20-day moving average, which settled at $0.8306. In addition, ProKidney Corp saw -56.73% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PROK starting from Weber Darin J., who sale 16,412 shares at the price of $2.50 back on Sep 19 ’24. After this action, Weber Darin J. now owns 103,480 shares of ProKidney Corp, valued at $41,030 using the latest closing price.
DARIN J WEBER, the Officer of ProKidney Corp, proposed sale 16,412 shares at $2.39 during a trade that took place back on Sep 19 ’24, which means that DARIN J WEBER is holding shares at $39,225 based on the most recent closing price.
Stock Fundamentals for PROK
Current profitability levels for the company are sitting at:
- -2416.79 for the present operating margin
The net margin for ProKidney Corp stands at -1344.07. The total capital return value is set at -0.45.
Based on ProKidney Corp (PROK), the company’s capital structure generated -0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -51.13. The debt to equity ratio resting at -0.0. The interest coverage ratio of the stock is -20408.44.
Currently, EBITDA for the company is -158.49 million with net debt to EBITDA at 0.61. When we switch over and look at the enterprise to sales, we see a ratio of 1544.75. The receivables turnover for the company is 0.03for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.93.
Conclusion
To put it simply, ProKidney Corp (PROK) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
